Lv62
1880 积分 2023-04-17 加入
Burden of osteoarthritis in China and Asia from 1990 to 2021 and projections to 2050: A systematic analysis for the Global Burden of Disease Study 2021
1小时前
已完结
Innovations in Arthroscopy, Instrumentation, and Image Visualization in Orthopaedic Sports Medicine
6小时前
求助中
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial
16天前
已完结
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
19天前
已完结
Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trial
23天前
已完结
The Efficacy of Liposomal Irinotecan Plus Fluorouracil/Leucovorin as First-Line Therapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
28天前
已完结
Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancreatic adenocarcinoma (NASOX): A multicenter phase I/IIa study
28天前
已完结
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
1个月前
已完结
Liposomal vs conventional irinotecan: safety profiles compared
1个月前
已完结
皖公网安备34019202002308
